TELA Bio, Inc. (TELA)

US — Healthcare Sector
Peers: TBIO  RCEL  CLPT  SGHT  TMCI  XGN  PHAT  KROS  TARA 

Automate Your Wheel Strategy on TELA

With Tiblio's Option Bot, you can configure your own wheel strategy including TELA - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol TELA
  • Rev/Share 1.5733
  • Book/Share 0.4004
  • PB 5.1704
  • Debt/Equity 2.3068
  • CurrentRatio 4.2178
  • ROIC -0.6478

 

  • MktCap 81878850.0
  • FreeCF/Share -0.8318
  • PFCF -2.1746
  • PE -2.1569
  • Debt/Assets 0.5412
  • DivYield 0
  • ROE -4.0245

 

  • Rating C-
  • Score 1
  • Recommendation Strong Sell
  • P/E Score 1
  • DCF Score 1
  • P/B Score 3
  • D/E Score 1

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
Downgrade TELA Piper Sandler Overweight Neutral $5 $2 March 21, 2025

News

TELA Bio Appoints Jeffrey Blizard as President
TELA
Published: June 02, 2025 by: GlobeNewsWire
Sentiment: Neutral

Company Further Strengthens Executive Leadership Team to Drive Next Phase of Growth Company Further Strengthens Executive Leadership Team to Drive Next Phase of Growth

Read More
image for news TELA Bio Appoints Jeffrey Blizard as President

About TELA Bio, Inc. (TELA)

  • IPO Date 2019-11-08
  • Website https://www.telabio.com
  • Industry Medical - Devices
  • CEO Antony Koblish
  • Employees 209

TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. The company markets its products through a single direct sales force, principally in the United States. TELA Bio, Inc. was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.